BCG as an adjunct or alternative vaccine to prevent COVID-19?

J Travel Med. 2020 Nov 9;27(7):taaa175. doi: 10.1093/jtm/taaa175.

Authors

Chien-Hsiang Weng¹, Philip A Chan²

Affiliations

¹ Department of Family Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA.
² Department of Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA.

No abstract available

Keywords: COVID-19 vaccine; SARS-CoV-2; immune training; nonspecific effects; off-target protection; pandemic; tuberculosis.

Publication types

Review

MeSH terms

Adjuvants, Immunologic / administration & dosage
BCG Vaccine / administration & dosage*
COVID-19
Communicable Disease Control / methods*
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Female
Humans
Immunity, Innate / physiology*
Male
Pandemics / prevention & control*
Pandemics / statistics & numerical data
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
Prognosis
Risk Assessment
Vaccination / statistics & numerical data*

Substances

Adjuvants, Immunologic
BCG Vaccine